Toni Weinschenk

Corporate Officer/Principal at IMMATICS N.V.

Net worth: - $ as of 2026-05-30

56 year

Health Technology

Consumer Services

Profile

Toni Weinschenk is the founder of Immatics Biotechnologies GmbH, founded in 2000, holding the title of Chief Innovation Officer since 2020.
Dr. Weinschenk is the founder of Immatics US, Inc., founded in 2015, holding the title of Chief Technology Officer since 2015.
Dr. Weinschenk currently holds the position of Chief Innovation Officer at Immatics NV since 2020.
Dr. Weinschenk earned a doctorate from Eberhard Karls Universität Tübingen.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
IMMATICS N.V. -.--%	2026-03-17	0 ( -.--% )	- $	2026-05-30

Toni Weinschenk active positions

Companies	Position	Start
IMMATICS N.V.	Corporate Officer/Principal	2019-12-31
Immatics Biotechnologies GmbH Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer	Founder	1999-12-31
Immatics US, Inc. Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer	Founder	2015-05-31

All active positions of Toni Weinschenk

Training of Toni Weinschenk

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Toni Weinschenk's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Immatics Biotechnologies GmbH Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer	Health Technology
Eberhard Karls Universität Tübingen Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Immatics US, Inc. Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer	Health Technology
Immatics NV Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments	Health Technology